(endo-n-8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1h-benzimidazol-1-carboxamide has been researched along with p-chloroamphetamine in 1 studies
| Studies ((endo-n-8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1h-benzimidazol-1-carboxamide) | Trials ((endo-n-8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1h-benzimidazol-1-carboxamide) | Recent Studies (post-2010) ((endo-n-8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1h-benzimidazol-1-carboxamide) | Studies (p-chloroamphetamine) | Trials (p-chloroamphetamine) | Recent Studies (post-2010) (p-chloroamphetamine) |
|---|---|---|---|---|---|
| 24 | 0 | 0 | 656 | 0 | 31 |
| Protein | Taxonomy | (endo-n-8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1h-benzimidazol-1-carboxamide (IC50) | p-chloroamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.207 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, E; Meneses, A | 1 |
1 other study(ies) available for (endo-n-8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-2,3-dihydro-3-ethyl-2-oxo-1h-benzimidazol-1-carboxamide and p-chloroamphetamine
| Article | Year |
|---|---|
Effects of 5-HT4 receptor agonists and antagonists in learning.
Topics: Animals; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Conditioning, Operant; Drug Evaluation, Preclinical; Male; p-Chloroamphetamine; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |